Administrative Core

行政核心

基本信息

  • 批准号:
    10212459
  • 负责人:
  • 金额:
    $ 30.24万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Abstract The Brain Vascular Malformation Consortium (BVMC) Administrative Core (AC) is a central resource for addressing a wide range of administrative issues related to the conduct of proposed research, including human research regulatory issues, publications, reports, and fiscal management. The AC will provide administrative support to all BVMC Projects, and will provide assistance in progress report generation, manuscript preparation, and central scheduling of research meetings and seminars. In addition, the AC will provide advice on study design, and statistical and genetic support for BVMC Projects. The AC is essential for the coordination of the interdisciplinary clinical programs that are part of the BVMC, and will manage the Career Enhancement Core and the Pilot/Feasibility Core. The overarching goal will be to provide a mutually supportive environment to foster clinical research activities in the component projects through its various committees, meetings, and interactions regarding research design and data analysis. Aim 1: Provide scientific leadership for the BVMC. The AC includes key personnel with extensive and complementary experience in designing and conducting clinical research studies, including a statistician, epidemiologist, geneticist, and a vascular neurosurgeon (clinical liaison). In addition, the AC has research and clinical expertise in brain vascular malformations and the diseases under study. Combined with the patient advocacy group representatives, the AC will provide scientific support and direction for all the Projects. Aim 2: Coordinate meetings and provide supportive environment for mutual exchange of ideas. The AC is available to the Leaders and Co-Leaders of all Cores and Projects for scheduling and coordinating committee meetings and research seminars. This includes scheduling and arranging travel and hotel accommodations for BVMC members to attend the annual in-person meeting in conjunction with Patient Advocacy Group (PAG)- sponsored scientific meetings. Aim 3: Provide administrative support to BVMC Projects. The AC will provide assistance in preparation of manuscripts and presentations, progress report generation, keeping track of current IRB approvals, and assisting Project/Core Leaders with fiscal management reports. The AC will also be responsible for updating the BVMC web server with relevant announcements, seminars, and a portal to research results. The AC will also be responsible for relaying all communications to/from the RDCRN Data Management and Coordinating Center (DMCC), NIH, and the larger RDCRC network.
摘要 脑血管畸形联盟(BVMC)管理核心(AC)是一个中心资源, 解决与拟议研究的进行有关的广泛的行政问题,包括人类 研究监管问题、出版物、报告和财务管理。AC将提供行政 支持所有BVMC项目,并将在进度报告生成,手稿准备, 并集中安排研究会议和研讨会。此外,顾问委员会亦会提供有关研究的意见, BVMC项目的设计、统计和遗传支持。行政协调会对于协调 跨学科的临床计划,是BVMC的一部分,并将管理职业提升核心 和试点/可行性核心。总体目标是提供一个相互支持的环境, 通过各种委员会、会议和互动,在组成项目中开展临床研究活动 关于研究设计和数据分析。 目标1:为BVMC提供科学领导。AC包括具有广泛和 设计和开展临床研究的补充经验,包括统计学家, 流行病学家、遗传学家和血管神经外科医生(临床联络员)。此外,AC还进行了研究, 在脑血管畸形和正在研究的疾病的临床专业知识。结合患者 咨询委员会将为所有项目提供科学支持和指导。 目标2:协调会议,为相互交流意见提供支持性环境。交流 可供所有核心和项目的领导人和联合领导人安排和协调委员会 会议和研究研讨会。这包括安排和安排旅行和酒店住宿, BVMC成员将与患者倡导小组(PAG)一起参加年度面对面会议- 主办科学会议。 目标3:为BVMC项目提供行政支持。咨询委员会将提供协助, 手稿和演示文稿,进度报告生成,跟踪当前IRB批准,并协助 负责财务管理报告的项目/核心领导人。AC还将负责更新BVMC 提供相关公告、研讨会和研究成果门户网站的网络服务器。AC也将 负责中继RDCRN数据管理和协调中心的所有通信 (DMCC),NIH和更大的RDCRC网络。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Helen Kim其他文献

Helen Kim的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Helen Kim', 18)}}的其他基金

Brain Vascular Malformation Consortium: Predictor's of Clinical Course
脑血管畸形联盟:临床过程的预测因子
  • 批准号:
    9804270
  • 财政年份:
    2009
  • 资助金额:
    $ 30.24万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10673812
  • 财政年份:
    2009
  • 资助金额:
    $ 30.24万
  • 项目类别:
Brain Vascular Malformation Consortium: Predictor's of Clinical Course
脑血管畸形联盟:临床过程的预测因子
  • 批准号:
    10673774
  • 财政年份:
    2009
  • 资助金额:
    $ 30.24万
  • 项目类别:
Modifiers of Disease Severity and Progression in Cerebral Cavernous Malformation
脑海绵状血管瘤疾病严重程度和进展的修饰因素
  • 批准号:
    10673816
  • 财政年份:
    2009
  • 资助金额:
    $ 30.24万
  • 项目类别:
Modifiers of Disease Severity and Progression in Cerebral Cavernous Malformation
脑海绵状血管瘤疾病严重程度和进展的修饰因素
  • 批准号:
    10675201
  • 财政年份:
    2009
  • 资助金额:
    $ 30.24万
  • 项目类别:
System Wide Operations for Rare Disorders (SWORD)
罕见疾病全系统操作 (SWORD)
  • 批准号:
    10832417
  • 财政年份:
    2009
  • 资助金额:
    $ 30.24万
  • 项目类别:
Brain Vascular Malformation Consortium: Predictor's of Clinical Course
脑血管畸形联盟:临床过程的预测因子
  • 批准号:
    10212458
  • 财政年份:
    2009
  • 资助金额:
    $ 30.24万
  • 项目类别:
Brain Vascular Malformation Consortium: Predictor's of Clinical Course
脑血管畸形联盟:临床过程的预测因子
  • 批准号:
    10442413
  • 财政年份:
    2009
  • 资助金额:
    $ 30.24万
  • 项目类别:
Modifiers of Disease Severity and Progression in Cerebral Cavernous Malformation
脑海绵状血管瘤疾病严重程度和进展的修饰因素
  • 批准号:
    10212460
  • 财政年份:
    2009
  • 资助金额:
    $ 30.24万
  • 项目类别:
Brain Vascular Malformation Consortium: Predictor's of Clinical Course
脑血管畸形联盟:临床过程的预测因子
  • 批准号:
    10675199
  • 财政年份:
    2009
  • 资助金额:
    $ 30.24万
  • 项目类别:

相似海外基金

A methodology to connect functionalized gonadal constructs to a chick embryo through mechanically induced blood vessels from an egg
一种通过鸡蛋机械诱导血管将功能化性腺结构连接到鸡胚胎的方法
  • 批准号:
    24K15741
  • 财政年份:
    2024
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
All-in-One Smart Artificial Blood Vessels
一体化智能人造血管
  • 批准号:
    EP/X027171/2
  • 财政年份:
    2024
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Fellowship
Development of nextgeneration cellular artificial blood vessels for coronary artery bypass surgery using bio-3D printer
使用生物 3D 打印机开发用于冠状动脉搭桥手术的下一代细胞人造血管
  • 批准号:
    23H02991
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Tissue engineered blood vessels
组织工程血管
  • 批准号:
    2891099
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Studentship
ealization of navigation surgery by automatic recognition of stomach and surrounding blood vessels using artificial intelligence
利用人工智能自动识别胃及周围血管,实现导航手术
  • 批准号:
    23K07176
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Realtime observation and optical control of living microbial probes in blood vessels
血管内活微生物探针的实时观察和光学控制
  • 批准号:
    23H00551
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Creation of a technique for visualization of stress concentration in blood and blood vessels by combined measurement of photoelasticity and ultrasonic Doppler velocimetry
通过光弹性和超声多普勒测速的组合测量,创建了一种可视化血管中应力集中的技术
  • 批准号:
    23H01343
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Shear stress-activated synthetic cells for targeted drug release in stenotic blood vessels
剪切应力激活合成细胞用于狭窄血管中的靶向药物释放
  • 批准号:
    10749217
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
Creation of 3D tissue culture system integrated with blood vessels and autonomic nerves
打造血管与植物神经融合的3D组织培养系统
  • 批准号:
    23H01827
  • 财政年份:
    2023
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Biological function of osteoporotic drugs on bone-specific blood vessels and perivascular cells
骨质疏松药物对骨特异性血管和血管周围细胞的生物学功能
  • 批准号:
    22K21006
  • 财政年份:
    2022
  • 资助金额:
    $ 30.24万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了